New mRNA vaccine aims to stop cancer from coming back
Disease control
Recruiting now
This early-stage study tests a personalized mRNA vaccine (RGL-270) in people with solid tumors who have a high chance of the cancer returning after standard treatment. The vaccine is designed to train the immune system to recognize and attack leftover cancer cells. Some participa…
Phase: PHASE1 • Sponsor: Xian-Jun Yu • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC